Skip to Main Content

Mahesh Anantha, MD a Finalist for the Coffman Award from the American Heart Association

December 09, 2020
by Elisabeth Reitman

Mahesh Anantha, MD, presented his work as a finalist for the prestigious Jay D. Coffman Early Career Investigator Award for Peripheral Arterial Disease for his work on critical limb ischemia (CLI), “Trends in Hospital Admissions and Outcomes in Patients with Critical Limb Ischemia – Analysis from a National Database.” The results of the project will be published in the journal Circulation: Cardiovascular Quality and Outcomes.

“Chronic limb threatening ischemia is highly prevalent, however recent trends in in-hospital mortality, major amputations, length of stay, and cost of admissions have not been well documented. CLI admissions continue to increase and despite novel technologies, risk factors continue to increase and significant disease burden remains,” said Anantha.

Anantha earned his medical degree from Madras Medical College in Chennai, India, before moving to the United States to pursue research training at the Mayo Clinic. This was followed by an internal medicine residency and chief residency at the Creighton University School of Medicine, and a cardiovascular disease fellowship at the University of Minnesota. He is currently completing his interventional cardiology fellowship training at the University of Arizona Banner Health.

Prior to his interventional coronary year, Anantha enrolled in an endovascular fellowship at Yale Cardiovascular Medicine. As a researcher with the Vascular Medicine OutcomeS (VAMOS) program, he has published in multiple peer-reviewed journals on peripheral arterial disease, carotid artery stenosis, and novel therapies such as drug-coated balloon angioplasty. His mentors, Kim Smolderen, PhD and Carlos Mena-Hurtado, MD, are the co-directors of the program.

“Mahesh has been an incredible asset to the VAMOS team. He is a dedicated clinician and researcher with a bright future,” said Mena-Hurtado.

CLI admissions continue to increase and despite novel technologies, risk factors continue to increase and significant disease burden remains.

​Mahesh Anantha, MD

The abstract was published in Circulation.

Submitted by Elisabeth Reitman on December 10, 2020